Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-85,page-paged-85,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.7.0,vc_responsive

CLIENT NEWS

 

 

  • InflaRx Receives Approval to Initiate Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum
    27 February 2019
    www.inflarx.com
  • NOXXON files application for Phase ½ clinical trial combining NOX-A12 & radiotherapy for the treatment of brain cancer patients
    27 February 2019
    www.noxxon.com
  • Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers
    26 February 2019
    www.medigene.com
  • Verona Pharma Reports Financial Results for Full Year Ended December 31, 2018 and Provides Clinical Development Update
    26 February 2019
    www.veronapharma.com
  • Medigene AG: Medigene presents development strategies for TCR therapies at CAR-TCR Summit Europe
    26 February 2019
    www.medigene.com
  • Medigene AG: European Patent covering TCR library suitable for the development of neoantigen-specific TCRs
    25 February 2019
    www.medigene.com
  • Medigene AG: Medigene participates at upcoming conferences
    22 February 2019
    www.medigene.com
  • MorphoSys AG: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire
    19 February 2019
    www.morphosys.com
  • Nutricion Center NC and ADL Bionatur Solutions sign a strategic alliance to tackle weight control by rebalancing the gut microbiome
    19 February 2019
    www.adlbionatur.com
  • Motif Bio plc: Motif Bio Conference Call and Webcast
    19 February 2019
    www.motifbio.com